Closing General Session: A New Era in Alzheimer’s Innovation
Sponsored by PhRMA
Thursday, March 29 | 8:00–9:30 AM
This session will educate audience members on the work the industry is doing to search for treatments and cures in the Alzheimer's space and beyond, expand on the difficulty of researching and bringing medicines to market, including the high number of failures, and highlight the patient experience and the need for access to therapies.
Moderated by Lori Reilly, JD, Executive Vice President for Policy, Research & Membership, PhRMA
Presenters: Bob Blancato, MPA, President, Matz, Blancato & Associates; Phyllis Ferrell, MBA, Vice President of the global Alzheimer's Disease Team, Eli Lilly And Company; Eric Karran, PhD, VP, Distinguished Research Fellow, Foundational Neuroscience Center, Abb Vie Inc; Matthew Kennedy, PhD, Director, Early Discovery Neuroscience, Merck & Co. Inc; Brian Kursonis, Founder, withALZmyHeart.com; Jason Resendez, Executiver Director, LatinosAgainstAlzheimer's Coalition and Chief of Staff, UsAgainstAlzheimer's.